Peter Lykke Eriksen

Aarhus University

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (16)

Rajiv Jalan

UNITED KINGDOM

View details

Kristoffer Kjærgaard

Aarhus University

DENMARK

View details

Rune Hartmann

Professor

Aarhus University

DENMARK

View details

Sara Lind Jepsen

Københavns Universitet

DENMARK

View details

Anna Skab Hassing

Københavns Universitet

DENMARK

View details

Anne M Landau

Aarhus University

DENMARK

View details

Daniel Andersen

Københavns Universitet

DENMARK

View details

Katrine Douglas Galsgaard

Københavns Universitet

DENMARK

View details

Karen Louise Thomsen

DENMARK

View details

Stephen Hamilton-Dutoit

Aarhus University

DENMARK

View details

Anne Catrine Daugaard Mikkelsen

Aarhus University Hospital

DENMARK

View details

Cecilie Bay-Richter

Associate Professor

Aarhus University

DENMARK

View details

Michelle Møhlenberg

Aarhus University

DENMARK

View details

Morten Dall

Københavns Universitet

DENMARK

View details

Cathrine Ørskov

Københavns Universitet

DENMARK

View details

Christian Lodberg Hvas

Aarhus University Hospital

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Lykke Eriksen

Research Interests

Contact this professor

Articles (14)

Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation

Cerebral Aspects of Portal Hypertension

Svær hepatisk kolestase efter behandling med amoxicillin / clavulansyre

Clearance and production of ammonia quantified in humans by constant ammonia infusion – the effects of cirrhosis and ammonia-targeting treatments

Further on ammonia concentration, -clearance, -removal, and -production

Role of ammonia in NAFLD: An unusual suspect

Correction: Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved (BMC Gastroenterology, (2022), 22, 1, (541), 10.1186/s12876-022-02574-6)

The presence of interferon affects the progression of non-alcoholic fatty liver disease

Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved

Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease

Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection

Cognitive dysfunction in non-alcoholic fatty liver disease - current knowledge, mechanisms and perspectives

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis

Collaborators (16)

Rajiv Jalan

Kristoffer Kjærgaard

Rune Hartmann

Sara Lind Jepsen

Anna Skab Hassing

Anne M Landau

Daniel Andersen

Katrine Douglas Galsgaard

Karen Louise Thomsen

Stephen Hamilton-Dutoit

Anne Catrine Daugaard Mikkelsen

Cecilie Bay-Richter

Michelle Møhlenberg

Morten Dall

Cathrine Ørskov

Christian Lodberg Hvas

Make your next move.